Kura Oncology Inc. (KURA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Kura Oncology Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.72
+8.28% today
Market cap
$881M
Overall quality
—
Kronos AI 30-day
+3.0%
7 of 8 simulated paths end higher
Kura Oncology Inc. (KURA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $881M. It trades at $10.72, up 8.28% today. 9 analysts' average target of $25.79 implies +140.6% from today's price. Kronos AI's 30-day forecast is +3.0% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $25.79 |
| Low – high | $12.15 – $40.00 |
| Analysts | 9 |
| Upside to average | +140.6% |
Kronos AI 30-day forecast
| Expected close | $10.19 (+3.0%) |
| Likely range | −0.7% … +13.0% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.